Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease
- PMID: 23617752
- PMCID: PMC3656143
- DOI: 10.1111/jgs.12220
Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease
Abstract
Objectives: To estimate the effects of depression diagnosis and antidepressant treatment on 2-year all-cause mortality in Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) and determine whether Social Security Disability Insurance (SSDI) eligibility modifies these relationships.
Design: Retrospective cohort study.
Setting: A 5% random sample of Medicare beneficiaries aged 65 and older in stand-alone Part D plans in 2006 to 2008.
Participants: Beneficiaries diagnosed with COPD and continuously enrolled in Medicare Parts A, B, and D (N = 75,699).
Measurements: Depression diagnosis was assessed at baseline (2006). Evidence of antidepressant treatment was measured across time. Covariates included baseline characteristics, comorbidities, and disease severity. Survival analyses using Cox proportional hazards models estimated 2-year mortality associated with depression diagnosis or antidepressant treatment (in beneficiaries with depression). Interaction terms of SSDI eligibility with baseline depression and time-dependent antidepressant treatment were tested.
Results: More than one-fifth (21.6%) of beneficiaries with COPD had a depression diagnosis at baseline, and 82.1% of those received antidepressants. Nearly one-sixth (16.3%) of the sample were SSDI eligible. Baseline depression heightened risk of death (hazard ratio = 1.13, 95% confidence interval = 1.09-1.18) in beneficiaries who were not eligible for SSDI. In beneficiaries with depression, the association between antidepressant treatment and lower mortality was different according to SSDI eligibility status.
Conclusion: Social Security Disability Insurance eligibility modifies the effects of depression and antidepressant treatment on mortality in Medicare beneficiaries with COPD. These data suggest that clinicians should identify and treat depression in individuals with COPD, but further studies are needed to determine the effect of these interventions.
© 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.
Conflict of interest statement
Similar articles
-
Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.Ann Am Thorac Soc. 2016 Sep;13(9):1497-504. doi: 10.1513/AnnalsATS.201602-136OC. Ann Am Thorac Soc. 2016. PMID: 27332765 Free PMC article.
-
Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD.Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):612-8. doi: 10.1016/j.genhosppsych.2013.06.005. Epub 2013 Jul 18. Gen Hosp Psychiatry. 2013. PMID: 23871313
-
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.Int J Geriatr Psychiatry. 2014 Jan;29(1):49-57. doi: 10.1002/gps.3968. Epub 2013 Apr 19. Int J Geriatr Psychiatry. 2014. PMID: 23606418 Free PMC article.
-
Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.Ann Am Thorac Soc. 2015 Dec;12(12):1805-12. doi: 10.1513/AnnalsATS.201504-250OC. Ann Am Thorac Soc. 2015. PMID: 26394180 Free PMC article.
-
Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes.Drugs Aging. 2014 Jul;31(7):483-92. doi: 10.1007/s40266-014-0186-0. Drugs Aging. 2014. PMID: 24902934 Free PMC article. Review.
Cited by
-
Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.Ann Am Thorac Soc. 2016 Sep;13(9):1497-504. doi: 10.1513/AnnalsATS.201602-136OC. Ann Am Thorac Soc. 2016. PMID: 27332765 Free PMC article.
-
Managing comorbidities in COPD.Int J Chron Obstruct Pulmon Dis. 2015 Jan 7;10:95-109. doi: 10.2147/COPD.S54473. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25609943 Free PMC article. Review.
-
The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study.Int J Geriatr Psychiatry. 2018 Feb;33(2):e212-e220. doi: 10.1002/gps.4772. Epub 2017 Aug 22. Int J Geriatr Psychiatry. 2018. PMID: 28833488 Free PMC article.
-
Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression.Curr Med Res Opin. 2017 Feb;33(2):201-208. doi: 10.1080/03007995.2016.1248383. Epub 2016 Nov 11. Curr Med Res Opin. 2017. PMID: 27733085 Free PMC article.
-
Depression and risk of hospitalization for pneumonia in a cohort study of older Americans.J Psychosom Res. 2014 Dec;77(6):528-34. doi: 10.1016/j.jpsychores.2014.08.002. Epub 2014 Aug 11. J Psychosom Res. 2014. PMID: 25139125 Free PMC article.
References
-
- Centers for Disease Control and Prevention. [Accessed February 15, 2011];Deaths: Preliminary Data for 2008. 2010 at http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf. - PubMed
-
- American Lung Association. Trends in Chronic Obstructive Bronchitis and Emphysema: Morbidity and Mortality. American Lung Association; 2010. [Accessed on May 20, 2010]. Epidemiology & Statistics Unit, Research and Program Services.
-
- Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–1211. - PubMed
-
- Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12:113–117. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical